Lindus Health secures grants from the Innovate UK Smart Grant and funding from investors to help accelerate clinical research trials using technology platforms and machine learning.
As a result of the cash infusion, the company is now beginning trials to find innovative treatments for a range of conditions, including tinnitus, insomnia, menopause and childhood myopia.
Lindus Health uses its technology platform and machine learning to manage trials from start to finish. The CitrusClinical platform enables improved patient experience, data visibility and data quality.
This technology can significantly reduce the time it takes to get therapeutics approved and brought to market. According to the company, tests are completed three times faster than previous industry standards.
£6.5 funding to accelerate trial progress
£6 million has been raised from investors including Firstmination, Seedcamp and Peter Thiel.
Lindus Health has also received around £500,000 from the Innovate UK Smart Grant, part of UK Research and Innovation (UKRI). UKRI evaluators described the institute’s work in machine learning and data science as “a very worthwhile and innovative project”.
Lindus Health co-founder Michael Young said: “Clinical trials are the biggest bottleneck in improving human health. We are working with high-growth companies developing the next wave of breakthrough therapies to accelerate the clinical trial process. increase.
“It is exciting to work with government and industry pioneers to revolutionize clinical trials and bring treatments that benefit patients faster.
“From monitoring trial data in real time to using machine learning to predict trial outcomes and improve trial design proactively, we are simplifying and accelerating the trial process to put patients first. I want to think.”
Going forward, the company plans to use the funding to accelerate the use of machine learning and data science to revolutionize clinical trials. In doing so, treatment can be delivered to patients more quickly, helping to improve and prolong life.
The company will face a number of challenges. The company is working with Pharmanovia to use digital technology to find hard-to-reach insomniacs and assess the safety and efficacy of treatments for severe insomnia. He also has a 200-person trial evaluating Oto’s digital tinnitus solution compared to face-to-face therapy.
Lindus Health is also conducting a type 2 diabetes trial with George Medicines, a menopausal symptoms trial with Bonafide Health, and a Myopia X treatment trial for children with progressive myopia with Dopavision.
last year we saw The NHS Somerset, Wiltshire, Avon and Gloucester (SWAG) Cancer Alliance partners with Inspirata to use AI to rapidly match patients to relevant trials.
